⌘K

Login Start Free

Home/Filings/4/0001144204-10-054863

4//SEC Filing

Maslan Andrew Scott 4

Accession 0001144204-10-054863

CIK 0001091596other

View on SEC.gov Company Profile

Filed

Oct 20, 8:00 PM ET

Accepted

Oct 21, 2:11 PM ET

Size

5.0 KB

Accession

0001144204-10-054863

Insider Transaction Report

Form 4

Period: 2010-10-15

CYTOMEDIX INCGTF

Maslan Andrew Scott

Chief Financial Officer

Transactions

Other
Common Stock
2010-10-15+540→ 57,520 total

Footnotes (1)

[F1]Received pursuant to a stock dividend on the Company's outstanding Series D Convertible Preferred Stock.

Documents

1 file

4
v199613_ex.xmlPrimary

Issuer

CYTOMEDIX INC

CIK 0001091596

Entity typeother

Related Parties

1

filerCIK 0001332669

Filing Metadata

Form type: 4
Filed: Oct 20, 8:00 PM ET
Accepted: Oct 21, 2:11 PM ET
Size: 5.0 KB

View on SEC.gov